StockData
SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Sanara MedTech Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$33.14−0.02 (-0.06%)

Close on Oct 19, 2026

Market cap
$287.08M
P/E (TTM)
–
Dividend yield
–

Sanara MedTech Inc. revenue by segment

By business segment

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Sanara Surgical [Member]––––$25.80M$23.43M$26.31M$21.67M$20.16M$18.54M$17.69M$16.02M––
THP [Member]––––$26.58K–––––$0$0––

By product or service

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Soft Tissue Repair Products [Member]$25.24M$24.94M$24.73M$23.42M$22.66M$20.53M$23.54M$18.86M$17.64M$16.08M$15.08M$13.63M89.7%+11.4%
Bone Fusion Products [Member]$2.89M$2.86M$2.82M$2.91M$3.14M$2.90M$2.77M$2.81M$2.52M$2.45M$2.56M$2.34M10.3%-7.9%
Royalty [Member]–––––––$0$906–$50.25K$50.25K––
SaaS [Member]––––$26.58K–––––––––

By region

From the segment and revenue-disaggregation notes of Sanara MedTech's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.